<DOC>
	<DOCNO>NCT02982577</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness spray basis pilocarpine salivary flow patient xerostomia , radiation therapy , primary Sjögren 's Syndrome treat Clinics Hospital Faculty Medicine Ribeirão Preto ( HCFMRP-USP ) , impact quality life .</brief_summary>
	<brief_title>Effect Pilocarpine Patients With Xerostomia</brief_title>
	<detailed_description>There two group : Group 1 ( G1 ) - use spray pilocarpine three month washout period month , use spray without pilocarpine another three month ; Group 2 ( G2 ) - use spray without pilocarpine three month washout period month , use spray pilocarpine another three month ( randomize , control , duble blind crossover study ) . Participants submit OHIP-14 , Xerostomia Inventory ( XI ) salivary flow measurement start therapy - baseline ( T0 ) , one ( T2 ) , two ( T3 ) three ( T4 ) month start use spray , washout , crossover occur parameter measure period ( T0 ' , T2 ' , T3 ' T4 ' ) , measure one hour saliva ( T1 T1 ' ) baseline .</detailed_description>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Pilocarpine</mesh_term>
	<criteria>Age equal superior 18 year ; Both gender ; Lucid without diagnosis psychiatric disorder ; Diagnosed head neck cancer treat period 5 year radiotherapy major salivary gland ( parotid , submandibular sublingual ) include radiation field ; Primary Sjögren 's syndrome diagnosis make AmericanEuropean criterion . Sensitivity pilocarpine Secondary Sjögren 's syndrome ; Type II diabetes mellitus ; AIDS ; pregnant lactating woman ; Glaucoma ; Uncontrolled asthma ; Chronic obstructive pulmonary disease ; Renal diseases ; Severe cardiovascular disease ; Gastrointestinal disorder ; Hepatic insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Xerostomia</keyword>
	<keyword>Pilocarpine</keyword>
	<keyword>Quality life</keyword>
</DOC>